Haematological Disorders Respiratory
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Age between 16 and 65 years -Patient consenting to participate in the study (written consent) and to undergo a CBC (complete blood count). -In the event of an emergency department visit or admission to the ICU or pulmonology: patient presenting with a first episode of wheezing dyspnea, with a history strongly suggestive of asthma, and with later confirmation of the disease in pulmonology through pulmonary function testing (the patient will be recontacted after their pulmonology consultation if the initial management of the exacerbation took place in the emergency department, in order to obtain their pulmonary function test results). -In the event of an emergency department visit or ICU admission: patient already followed in pulmonology for chronic obstructive pulmonary disease, with a history strongly suggestive of asthma.
Exclusion criteria
Exclusion criteria: -For patients already followed in pulmonology who presented to the emergency department or were admitted to the intensive care unit: the diagnosis of asthma was ruled out after reviewing the patient’s medical records (the primary care physician will be contacted to obtain data from prior investigations). -For patients presenting with an inaugural episode of wheezing dyspnea in the emergency department or admitted to the intensive care unit: after consultation in pulmonology, the diagnosis of asthma was ruled out (the patient will be recontacted after their pulmonology consultation to obtain their pulmonary function tests). -Patients who withdraw consent at any point during the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the association between NLR and the initial severity of an asthma exacerbation. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the association between NLR and the course of an asthma exacerbation until discharge. | — |
Countries
Tunisia
Contacts
Dr